EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Comparison of The efficacy and safety of fractional erbium: YAG laser in combination with Tranexamic acid delivery by different methods versus Tranexamic acid alone: A systematic review and meta-analysis

Sara Mahfoud Hassan Alghamdi, Ahmed Mohammed Baabdullah, Dareen Bajamaan, Razan Almleaky, Mohammed Alahmadi, Mashael Sharaf, Badr Salem Aljohani, Rayan Alsaqri, Abdulrahman Ayman Alharbi

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04178-y ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Sara Mahfoud Hassan Alghamdi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia. Saraa.xv@gmail.com. Hauptthemen laut MEDLINE: Tranexamic Acid, Melanosis, Lasers, Solid-State. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melasma is a chronic hyperpigmentary disorder characterized by light-brown to bluish-gray patches. No single treatment is universally efficacious. Thus, a combination treatment should be applied. This Systematic review and meta-analysis aims to evaluate the efficacy of fractional erbium: YAG laser combined with tranexamic acid (TXA) delivery methods compared to TXA alone for melasma treatment. A comprehensive search was conducted across PubMed, Google Scholar, and Web of Science, including Randomized controlled trials (RCTs), cohort studies, and case series of patients diagnosed with melasma, excluding studies with high bias risk or low quality, studies involved patients with active skin infections, inflammatory skin conditions, or systemic diseases affecting healing, patients with keloid history or with concurrent anticoagulant or steroid use, and non-compliance with protocols. Studies should report at least one of the following outcomes such as improvement in melasma, incidence/severity of adverse events, objective pigment reduction, or treatment effect duration and relapse time. The risk of bias was assessed using the Newcastle-Ottawa Scale and the meta-analysis was conducted using a random-effects model (restricted maximum-likelihood estimator) to account for study variability. We included 13 studies involving a total of 585 participants. Most studies involved between 30 and 60 participants. Subgroup analysis of the modified Melasma Area and severity index showed no overall effect (standardized mean differences (SMDs) = -0.0802, p = 0.8685), with high heterogeneity (I² = 92.5%, p < 0.0001). A large positive effect was observed at 3 months (SMD = 1.9802) and a negative effect at 6 months (SMD = -0.7190) with significant differences. The overall effect of interventions on the Melasma Area and severity index was minimal (SMD = 0.0039, p = 0.9877), with moderate heterogeneity (I² = 50.3%, p = 0.1337). A small negative effect at 6 months was observed (SMD = -0.4234) and no significant effects at 3 months. There is no consistent or significant long-term impact on melasma severity. While some short-term improvements were observed, they often declined over time. Future studies are needed to better define the long-term effectiveness and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidMelanosisLasers, Solid-StateHumansTreatment OutcomeCombined Modality TherapyRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

EfficacyFractional erbium:yag laserMelasmaSafetyTranexamic acid

Substanzen

Tranexamic Acid

Autor:innen und Institutionen

  • Faculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia. Saraa.xv@gmail.com.
  • Department of Dermatology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Faculty of Medicine, Taibah University, Medina, Saudi Arabia.
  • Faculty of Medicine, University of Bisha, Bisha, Saudi Arabia.

Zitieren

APA

Alghamdi, S. M. H., Baabdullah, A. M., Bajamaan, D., Almleaky, R., Alahmadi, M., Sharaf, M., Aljohani, B. S., Alsaqri, R., & Alharbi, A. A. (2025). Comparison of The efficacy and safety of fractional erbium: YAG laser in combination with Tranexamic acid delivery by different methods versus Tranexamic acid alone: A systematic review and meta-analysis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04178-y

Vancouver

Alghamdi SMH, Baabdullah AM, Bajamaan D, Almleaky R, Alahmadi M, Sharaf M, et al. Comparison of The efficacy and safety of fractional erbium: YAG laser in combination with Tranexamic acid delivery by different methods versus Tranexamic acid alone: A systematic review and meta-analysis. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04178-y

BibTeX
@article{Alghamdi2025,
  author = {Alghamdi, Sara Mahfoud Hassan and Baabdullah, Ahmed Mohammed and Bajamaan, Dareen and Almleaky, Razan and Alahmadi, Mohammed and Sharaf, Mashael and Aljohani, Badr Salem and Alsaqri, Rayan and Alharbi, Abdulrahman Ayman},
  title = {Comparison of The efficacy and safety of fractional erbium: YAG laser in combination with Tranexamic acid delivery by different methods versus Tranexamic acid alone: A systematic review and meta-analysis},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04178-y}
}
Kostenlos starten →